Nest Egg ApS — Credit Rating and Financial Key Figures
CVR number: 33876793
Hejrevej 39, 2400 København NV
info@macurepharma.com
tel: 70204007
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 69 443.53 | 77 115.84 | 158 823.38 | 123 986.34 | 151 798.52 |
| Employee benefit expenses | -8 696.77 | -30 376.54 | -25 599.95 | -15 192.89 | -17 554.12 |
| Total depreciation | - 208.91 | - 297.54 | - 285.09 | -1 452.38 | - 637.77 |
| EBIT | 60 537.84 | 46 441.76 | 132 938.34 | 107 341.06 | 133 606.62 |
| Other financial income | 112.05 | 120.68 | 2 383.36 | 4 322.32 | |
| Other financial expenses | - 113.26 | - 224.06 | -1 104.79 | -2 422.77 | -14 573.12 |
| Pre-tax profit | 60 424.58 | 46 329.75 | 131 954.23 | 107 301.66 | 123 355.83 |
| Income taxes | -13 318.65 | -10 152.35 | -28 921.40 | -23 568.41 | -27 648.38 |
| Net earnings | 47 105.93 | 36 177.41 | 103 032.83 | 83 733.25 | 95 707.45 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 2 807.53 | 3 231.69 | 4 238.09 | 6 483.56 | 10 595.86 |
| Intangible assets total | 2 807.53 | 3 231.69 | 4 238.09 | 6 483.56 | 10 595.86 |
| Buildings | 683.90 | ||||
| Tangible assets total | 683.90 | ||||
| Investments total | 151.10 | 146.67 | 167.99 | 169.55 | 1 184.14 |
| Long term receivables total | |||||
| Raw materials and consumables | 1 008.76 | 1 549.63 | |||
| Finished products/goods | 23 895.91 | 25 911.55 | 28 969.00 | 28 035.76 | 32 950.36 |
| Advance payments | 214.72 | 238.14 | |||
| Inventories total | 23 895.91 | 25 911.55 | 28 969.00 | 29 259.23 | 34 738.14 |
| Current trade debtors | 23 954.44 | 53 364.31 | 91 143.49 | 52 935.44 | 57 410.92 |
| Prepayments and accrued income | 408.13 | 1 027.49 | 1 930.69 | ||
| Current other receivables | 1 624.86 | 13 944.73 | 32 338.67 | 67 690.81 | 97 719.74 |
| Current deferred tax assets | 239.15 | 1 362.51 | 446.02 | 214.67 | 5 140.67 |
| Short term receivables total | 25 818.45 | 68 671.56 | 124 336.31 | 121 868.40 | 162 202.03 |
| Cash and bank deposits | 24 687.91 | 53 321.00 | 49 079.97 | 82 121.09 | 31 310.42 |
| Cash and cash equivalents | 24 687.91 | 53 321.00 | 49 079.97 | 82 121.09 | 31 310.42 |
| Balance sheet total (assets) | 77 360.91 | 151 282.47 | 206 791.37 | 239 901.83 | 240 714.49 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 45 000.00 | 37 800.00 | 93 000.00 | 83 500.00 | 97 052.00 |
| Other reserves | 26.86 | - 382.27 | - 158.88 | - 581.46 | |
| Retained earnings | -37 892.22 | -28 586.29 | -85 408.88 | -65 876.05 | -79 194.80 |
| Profit of the financial year | 47 105.93 | 36 177.41 | 103 032.83 | 83 733.25 | 95 707.45 |
| Shareholders equity total | 54 293.71 | 45 497.98 | 110 321.68 | 101 278.32 | 113 063.19 |
| Provisions | 70.42 | ||||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 96.93 | 169.67 | |||
| Advances received | 464.78 | 63.30 | 120.75 | ||
| Current trade creditors | 12 223.64 | 57 284.31 | 41 993.21 | 109 373.94 | 119 237.44 |
| Current owed to participating | 31.32 | 23 310.37 | 2 372.11 | 91.48 | 139.88 |
| Short-term deferred tax liabilities | 1 416.00 | 340.59 | 19 545.48 | 17 282.03 | 1 828.11 |
| Other non-interest bearing current liabilities | 9 396.24 | 24 849.21 | 32 094.11 | 11 715.82 | 6 085.04 |
| Current liabilities total | 23 067.19 | 105 784.49 | 96 469.69 | 138 623.51 | 127 580.88 |
| Balance sheet total (liabilities) | 77 360.91 | 151 282.47 | 206 791.37 | 239 901.83 | 240 714.49 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.